Impact of age on efficacy of neoadjuvant chemoradiotherapy (CRT) in locally advanced rectal cancer (LARC)

Date 29 June 2016
Event ESMO World Congress on Gastrointestinal Cancer 2016
Session ESMO World Congress on Gastrointestinal Cancer 2016 - Abstracts book
Presenter G. Calderillo
Citation Annals of Oncology (2016) 27 (2): 1-85. 10.1093/annonc/mdw199
Authors G. Calderillo1, M. Herrera1, H. Lopez1, C. Diaz1, A. Padilla2, E. Ruiz-Garcia1, E. Trejo1
  • 1Instituto Nacional de Cancerologia, Tlalpan, Mexico, /
  • 2National Cancer Institute, Tlalpan, Mexico, /

Abstract

The incidence of rectal cancer in young patients is increasing; recent literature suggests that some clinical characteristics may influence the major rate of recurrence and lesser overall survival in comparison with adult patients. The present study aimed to explore the clinical characteristics of patients with early-onset (40 years of age (Group B).